Alevizaki Maria, Saltiki Katerina, Voidonikola Paraskevi, Mantzou Emily, Papamichael Christos, Stamatelopoulos Kimon
Endocrine Unit, Department of Endocrinology and Metabolism, Evgenidion Hospital, Athens, Greece.
Eur J Endocrinol. 2009 Sep;161(3):459-65. doi: 10.1530/EJE-09-0441.
Thyroid function parameters have been associated with obesity, but associations with the type of adiposity have not been examined. We used ultrasound (US) to assess regional adiposity and investigated associations of thyroid function with parameters of central obesity.
Cross-sectional study.
A total of 303 apparently healthy individuals (age 42.9+/-8.8, body mass index (BMI) 19.0-43.3, median 26.2 kg/m(2), 181 women) were examined for indices of the metabolic syndrome. BMI, waist and hip circumference, abdominal subcutaneous fat (SF), and preperitoneal fat (PF) layer was estimated. TSH, free thyroxine (fT(4)), triiodothyronine (T(3)), thyroid autoantibodies, insulin, glucose, and lipid levels were measured. Subjects receiving T(4) (9.2%) were excluded.
SF and SF/PF ratio were inversely correlated with fT(4) levels (r=-0.169, P=0.023, r=-0.193, P=0.009 respectively). In multivariate analysis, fT(4) was a predictor of SF and SF/PF, independently of age, sex, and smoking. SF correlated with TSH levels (r=0.149, P=0.037). PF and SF were positively associated with T(3) levels (r=0.245, P=0.004 and r=0.189, P=0.019 respectively). T(3) levels were positively associated with BMI (r=0.257, P=0.0004), waist perimeter (r=0.324, P<0.0001), and waist-to-hip ratio (WHR; r=0.363, P<0.0001). The T(3)/fT(4) ratio was positively correlated with SF (r=0.182, P=0.028), WHR (r=0.267, P=0.0003), and BMI (r=0.146, P=0.043).
Increasing SF accumulation as assessed by US is associated with lower fT(4) and higher TSH levels among euthyroid slightly overweight individuals. These associations indicate that subtle variation in thyroid function may participate in regional adiposity.
甲状腺功能参数已被证实与肥胖相关,但与肥胖类型的关联尚未得到研究。我们使用超声(US)评估局部肥胖情况,并研究甲状腺功能与中心性肥胖参数之间的关联。
横断面研究。
共对303名表面健康的个体(年龄42.9±8.8岁,体重指数(BMI)19.0 - 43.3,中位数26.2kg/m²,181名女性)进行代谢综合征指标检查。测量BMI、腰围和臀围、腹部皮下脂肪(SF)以及腹膜前脂肪(PF)层厚度。检测促甲状腺激素(TSH)、游离甲状腺素(fT₄)、三碘甲状腺原氨酸(T₃)、甲状腺自身抗体、胰岛素、血糖和血脂水平。排除正在接受T₄治疗的受试者(9.2%)。
SF和SF/PF比值与fT₄水平呈负相关(分别为r = -0.169,P = 0.023;r = -0.193,P = 0.009)。在多变量分析中,fT₄是SF和SF/PF的预测因子,独立于年龄、性别和吸烟因素。SF与TSH水平相关(r = 0.149,P = 0.037)。PF和SF与T₃水平呈正相关(分别为r = 0.245,P = 0.004;r = 0.189,P = 0.019)。T₃水平与BMI呈正相关(r = 0.257,P = 0.0004)、腰围呈正相关(r = 0.324,P < 0.0001)以及腰臀比(WHR;r = 0.363,P < 0.0001)。T₃/fT₄比值与SF呈正相关(r = 0.182,P = 0.028)、WHR呈正相关(r = 0.267,P = 0.0003)以及BMI呈正相关(r = 0.146,P = 0.043)。
在甲状腺功能正常的轻度超重个体中,通过超声评估发现SF积累增加与较低的fT₄水平和较高的TSH水平相关。这些关联表明甲状腺功能的细微变化可能参与局部肥胖的发生。